GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ThermoGenesis Holdings Inc (NAS:THMO) » Definitions » Beneish M-Score

ThermoGenesis Holdings (ThermoGenesis Holdings) Beneish M-Score : -8.40 (As of Apr. 26, 2024)


View and export this data going back to 1987. Start your Free Trial

What is ThermoGenesis Holdings Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -8.4 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for ThermoGenesis Holdings's Beneish M-Score or its related term are showing as below:

THMO' s Beneish M-Score Range Over the Past 10 Years
Min: -8.4   Med: -3.58   Max: 84.52
Current: -8.4

During the past 13 years, the highest Beneish M-Score of ThermoGenesis Holdings was 84.52. The lowest was -8.40. And the median was -3.58.


ThermoGenesis Holdings Beneish M-Score Historical Data

The historical data trend for ThermoGenesis Holdings's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ThermoGenesis Holdings Beneish M-Score Chart

ThermoGenesis Holdings Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.63 -1.52 -4.72 -1.85 -8.40

ThermoGenesis Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.85 -5.23 -5.78 -6.42 -8.40

Competitive Comparison of ThermoGenesis Holdings's Beneish M-Score

For the Medical Devices subindustry, ThermoGenesis Holdings's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ThermoGenesis Holdings's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ThermoGenesis Holdings's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where ThermoGenesis Holdings's Beneish M-Score falls into.



ThermoGenesis Holdings Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of ThermoGenesis Holdings for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.5648+0.528 * 1.2645+0.404 * 0.1328+0.892 * 0.901+0.115 * 0.9186
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.1065+4.679 * -1.063123-0.327 * 1.672
=-8.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was $0.95 Mil.
Revenue was 2.406 + 2.194 + 2.273 + 2.572 = $9.45 Mil.
Gross Profit was -0.038 + 0.395 + 0.469 + 1.105 = $1.93 Mil.
Total Current Assets was $5.18 Mil.
Total Assets was $11.23 Mil.
Property, Plant and Equipment(Net PPE) was $5.80 Mil.
Depreciation, Depletion and Amortization(DDA) was $1.15 Mil.
Selling, General, & Admin. Expense(SGA) was $7.22 Mil.
Total Current Liabilities was $11.76 Mil.
Long-Term Debt & Capital Lease Obligation was $2.90 Mil.
Net Income was -7.014 + -3.615 + -2.26 + -5.086 = $-17.98 Mil.
Non Operating Income was -2.014 + -0.065 + 0 + -0.234 = $-2.31 Mil.
Cash Flow from Operations was -2.043 + -0.251 + -0.812 + -0.615 = $-3.72 Mil.
Total Receivables was $1.87 Mil.
Revenue was 2.676 + 2.115 + 3.029 + 2.663 = $10.48 Mil.
Gross Profit was 0.394 + 0.437 + 0.939 + 0.94 = $2.71 Mil.
Total Current Assets was $10.88 Mil.
Total Assets was $19.39 Mil.
Property, Plant and Equipment(Net PPE) was $5.18 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.93 Mil.
Selling, General, & Admin. Expense(SGA) was $7.24 Mil.
Total Current Liabilities was $11.51 Mil.
Long-Term Debt & Capital Lease Obligation was $3.63 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(0.949 / 9.445) / (1.865 / 10.483)
=0.100476 / 0.177907
=0.5648

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(2.71 / 10.483) / (1.931 / 9.445)
=0.258514 / 0.204447
=1.2645

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (5.18 + 5.796) / 11.232) / (1 - (10.884 + 5.176) / 19.386)
=0.022792 / 0.171567
=0.1328

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=9.445 / 10.483
=0.901

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0.926 / (0.926 + 5.176)) / (1.147 / (1.147 + 5.796))
=0.151754 / 0.165202
=0.9186

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(7.221 / 9.445) / (7.243 / 10.483)
=0.764531 / 0.690928
=1.1065

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((2.9 + 11.762) / 11.232) / ((3.626 + 11.509) / 19.386)
=1.305377 / 0.780718
=1.672

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-17.975 - -2.313 - -3.721) / 11.232
=-1.063123

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

ThermoGenesis Holdings has a M-score of -8.40 suggests that the company is unlikely to be a manipulator.


ThermoGenesis Holdings Beneish M-Score Related Terms

Thank you for viewing the detailed overview of ThermoGenesis Holdings's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


ThermoGenesis Holdings (ThermoGenesis Holdings) Business Description

Traded in Other Exchanges
Address
2711 Citrus Road, Rancho Cordova, CA, USA, 95742
ThermoGenesis Holdings Inc develops, commercializes and markets a range of automated technologies for CAR-T and other cell-based therapies. The company currently markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally-closed CAR-TXpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. It offers the AutoXpress and BioArchive platforms for automated clinical bio-banking, PXP platform for point-of-care cell-based therapies and CAR-TXpress platform for bio-manufacturing for immuno-oncology applications.
Executives
Xiaochun Xu director 2453 S. ARCHER AVE., STE. B, CHICAGO IL 60616
Biao Xi director C/O THERMOGENESIS HOLDINGS, INC., 2711 CITRUS ROAD, RANCHO CORDOVA CA 95742
James Xu director 2453 S. ARCHER AVE, SUITE B, CHICAGO IL 60616
Haihong Zhu director 2711 CITRUS ROAD, RANCHO CORDOVA CA 95742
Debra Donaghy director C/O THERMOGENESIS HOLDINGS, INC., 2711 CITRUS RD., RANCHO CORDOVA CA 95742
Boyalife (hong Kong) Ltd 10 percent owner 2453 S. ARCHER AVE., STE. B, CHICAGO IL 60616
Thomis Joseph director MALEIZENSTRAAT 66, HERENT C9 B-3020
Boyalife Asset Holding Ii, Inc. 10 percent owner 2453 S. ARCHER AVE., SUITE B, CHICAGO IL 60616
Boyalife Group, Inc. 10 percent owner 2453 S. ARCHER AVE., SUITE B, CHICAGO IL 60616
Russell M Medford director 7935 FAWNDALE WAY, ATLANTA GA 30350
Mark Westgate director 350 CORPORATE BOULEVARD, ROBBINSVILLE NJ 08691
Jeffery Cauble officer: Principal Accounting Officer 2711 CITRUS CT., RANCHO CORDOVA CA 95742
Vivian H Liu director
Boyalife Investment Inc. 10 percent owner 2453 S. ARCHER AVE., STE. B, CHICAGO IL 60616
Mark Bagnall director 3876 BAY CENTER PLACE, HAYWARD CA 94545

ThermoGenesis Holdings (ThermoGenesis Holdings) Headlines

From GuruFocus